Upstream Process Intensification: Real-World Results

Sonnet BioTherapeutics Chief Technology Officer Susan Dexter, single-use and process intensification pioneer Parrish Galliher, and Bioprocess Online Chief Editor Matt Pillar joined at the last Bioprocess Online Live for an in-depth discussion on upstream process intensification in practice. 

Topics discussed included how to approach process intensification implementation, the cost, time, and productivity benefit potential, why Sonnet chose to intensify its upstream processes, and the technical, operational, and regulatory challenges that must be addressed.